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Abstract 
Four probes (i.e. D1-D4) for the selective and sensitive fluorogenic detection of HS
-
 
have been prepared and characterized. HEPES (10 mM, pH 7.4)-DMSO 99:1 v/v 
solutions of D1-D4 are essentially non-fluorescent. Changes in the emission using D1-
































) and oxidants (H2O2) demonstrated that only HS
-
 is able to induce the 
appearance of intense emission bands in the 400-520 nm range in the four probes. The 
selectivity observed was ascribed to a unique hydrogen sulfide-induced hydrolysis of 
the 2,4-dinitrophenyl ether moiety that yielded the corresponding free highly fluorescent 
alcohols. The potential detection of intracellular HS
-
 was also studied. 
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Introduction 
Hydrogen sulfide (H2S), a colourless and flammable gas with high solubility in water 
and in organic solvents, is well-known for its unpleasant “rotten eggs” smell. Hydrogen 
sulfide has been traditionally studied for its toxicity,(1) its presence as a corrosive 
industrial refuse and emission in the energy industry,(2) as parameter for geological 
activity,(3) as quality control of foods and as an important compound related with the 
presence of microbial activity in anaerobic environments.(4) Moreover, this simple 
molecule has been recently recognized to play a relevant role in living systems. For 
instance hydrogen sulfide has been documented to be the third gaseous transmitter (the 
other two being nitric oxide and carbon monoxide).(5-7)
 
The production of H2S in 
mammalian systems has been attributed to at least three endogenous enzymes, i.e. 
cystathionine b-synthase (CBS), cystathionine g-lyase (CSE), and 3-mercaptopyruvate 
sulfurtransferase (MPST).(8-11) These enzymes use cysteine or cysteine derivatives as 
substrates and convert them into hydrogen sulfide in different organs and tissues. In 
addition to these enzymatic pathways, there are also a range of simple chemical events 
that may liberate hydrogen sulfide from the intracellular pool of “labile” sulfur such as 
the so-called “sulfane pool” (compounds containing sulfur atoms bound only to other 
sulfur atoms).(12) The production of endogenous hydrogen sulfide and exogenous 
administration of hydrogen sulfide has been demonstrated to exert protective effects in 
many pathologies. For example, hydrogen sulfide has been shown to relax vascular 
smooth muscle, induce vasodilation of isolated blood vessels, and reduce blood 
pressure.(13) Hydrogen sulfide has proved also to inhibit leukocyte adherence in 
mesenteric microcirculation in vascular inflammation in rats, suggesting that hydrogen 
sulfide is a potent anti-inflammatory molecule.(14) Additionally, it has become evident 
that hydrogen sulfide is a potent antioxidant and, under chronic conditions, can up-
regulate antioxidant defense.(15) 
 However hydrogen sulfide exact mechanism of action and production in living 
systems is still under active investigation. For example it is known that hydrogen sulfide 
can react readily with methemoglobin to form sulfhemoglobin, which act as the 
metabolic sink for H2S. As a potential reductant, hydrogen sulfide is likely to be 
consumed by endogenous oxidant species such as hydrogen peroxide, superoxide, 
peroxynitrite, etc. This process is significant and it provides a mechanism by which the 
concentration of hydrogen sulfide changes. Besides, abnormal levels of hydrogen 
sulfide have been associated with various diseases such as chronic kidney disease, liver 
cirrhosis,(16) Alzheimer,(17) and Down syndrome.(18)
 
 Due to the important roles that hydrogen sulfide plays in environmental and in 
biological processes the development of selective detection systems for this compound 
has recently become a focus of importance. In particular it was a major challenge to 
clarify the complex contributions of H2S in certain diseases by finding methods for 
selective tracking of this small molecule within living systems. Current techniques for 
hydrogen sulfide detection, such as colorimetry,(19-21) electrochemical assays,(22) gas 
chromatography(23) and metal-induced sulfide precipitation(24) show some 
shortcomings typically involving destruction of the sample and/or poor selectivity. 
 In addition to the above mentioned classical methodologies, fluorescence is an 
attractive highly sensitive technique for studying biomolecule distribution in living 
cells. For instance, very recently, fluorescent probes for monitoring redox cycles in vivo 
have been described.(25) In this area, several fluorescent probes, designed taking into 
account supramolecular chemistry concepts, for the selective recognition of H2S or HS
-
 
have been described.(26) Most of the fluorescent probes reported are based of the 
hydrogen sulfide-induced reduction of azides or nitro moieties, electronically connected 
with a fluorophore, to amines.(27-36) This reduction induced perturbations in the 
electronic structure of the signaling unit that is reflected in emission changes. Another 
important group of probes are constructed under a displacement paradigm and are based 
on non-fluorescent Cu(II) complexes.(37-46) In these systems the hydrogen sulfide-
induced demetallation of the probes induced marked emission enhancements. Other 
sulfide-selective fluorescent probes used Michael type addition reactions coupled with 
emission changes.(47-50) Also, cyclization processes that yielded fluorescent 
compounds have recently been used for the design of fluorescent probes for sulfide 
anion.(51-53) In other examples, hydrolysis reactions coupled with emission changes 
have been also used for the preparation of other hydrogen sulfide sensitive probes.(54-
56) Finally, selenium containing BOPIPY dyes have also been used for the reversible 
detection of sulfide in solution and in living cells.(57,58) Among probes that used 
hydrolysis reactions, as far as we know only three probes containing 2,4-dinitrophenyl 
ethers have been described and used for the selective and sensitive recognition of HS
-
 
anion. In particular, Lin and co-workers prepared a NIR dye functionalized with a 2,4-
dinitrophenyl ether moiety.(59)
 
PBS (pH 7.0)-ethanol 9:1 v/v solutions containing 
CTAB and this probe were non-fluorescent whereas addition of increasing quantities of 
HS
-
 anion induced a progressive appearance of an emission band. This emission 
enhancement was ascribed to a thiolysis of the 2,4-dinitrophenyl ether moiety. The 
same sensing mechanism was used by Spring and co-workers that prepared a 1,8-
naphthalimide fluorophore equipped with a 2,4-dinitrophenyl ether group.(60)
 
Finally, 
Liu and Feng prepared an ESIPT (excited state intramolecular proton transfer) probe 
functionalized with a 2,4-dinitrophenyl ether moiety for the rapid chromo-fluorogenic 
recognition of hydrogen sulfide.(61) The above described facts demonstrate that the 
design of new fluorogenic probes for hydrogen sulfide is a timely field of interest. Such 
simple systems may be used to control H2S concentrations in target industrial processes, 
for in situ environmental, geological monitoring and detection of hydrogen sulfide 
levels in living systems. Nevertheless, in spite of these possible applications, there are 
still relatively few examples of optical probes for the selective and sensitive detection of 
hydrogen sulfide (vide ante). 
 Bearing in mind the above mentioned concepts and following our interest in the 
development of new approaches for optical sensing,(62) we show herein a family of 
chemodosimeters (D1-D4) composed by selected fluorophores functionalized with 2,4-
dinitrophenyl ether moieties for the detection of hydrogen sulfide. The synthesis and 
sensing features of probe D3 were recently published by us in a short 
communication.(63) These dosimeters were easily synthesized through nucleophilic 
aromatic substitution reactions with 1-fluro-2,4-dintrobenzene with different 
fluorophores. The four probes displayed sensing features in buffered aqueous solution 
containing 1% of DMSO and gave marked emission enhancements only in the presence 
of HS
-
 anion, whereas other bio-thiols were unable to induce emission changes. The 
probes showed excellent sensitivities, with limits of the detection in the 0.05-0.30 µM 
range, and some of the chemosensors were used for the fluorescence detection of both 
exogenous and endogenous HS
-
 in living cells. 
Results and discussion  
Synthesis and characterizations of the probes: The path of synthesis and the 
structures of probes D1-D4 are shown in Scheme 1. D1-D4 are 2,4-dinitrophenyl ether 
derivatives which are easily obtained in good yield (65 to 88%) through an aromatic 
nucleophilic substitution reaction between 1-fluoro-2,4-dinitrobenzene (1) and alcohols 
1c, 2a, 3a and 4b. Compounds 2a and 3a are commercially available. Alcohol 1c was 
prepared through the base-catalysed condensation between 4-hydroxybenzaldehyde (1a) 
and 4-picoline (1b), whereas alcohol 4b was obtained through methylation of 













Scheme 1. Synthesis and chemical structure of chemodosimeters D1-D4. 
 




C-NMR and HRMS. At this respect, 
the more indicative signals in the 
1
H-MNR spectra of dosimeter D1 in DMSO-D6 were 
the doublets centred at 7.81 and 7.32 ppm attributed to the protons of the trans double 
bond. Moreover the protons of the 2,4-dinitrophenyl ether moiety appeared at 8.91 (1H, 
d), 8.47 (1H, dd) and 7.57 (1H, d) ppm. On changing to chemodosimeter D2, the most 
characteristic signals in the 
1
H-NMR (CDCl3) spectrum were also those of the 2,4-
dinitrophenyl ether moiety centred at 8.97, 8.41 and 7.39 ppm. Nearly the same pattern 
was observed for D3 in which the dinitrophenyl ether protons were located at 8.93 (1H, 
d), 8.18 (1H, dd) and 7.83 (1H, d) ppm. Dealing with fluorescein derivative D4, the 






















































than those observed for D1-D3, whereas the methoxy moiety appeared as singlet at 3.76 
ppm (in DMSO-D6). 
Sensing features of the probes: The four synthesized probes contain a chromo-
fluorogenic subunit functionalized with a sulfide-sensitive 2,4-dinitrophenyl ether 
moiety. It is well known that the dinitrophenyl group has been often used for tyrosine 
protection in peptide synthesis.(64) The removal of this protective group is carried out 
using thiols under basic conditions. In our prepared probes the dinitrophenyl ether was 
electronically coupled with the fluorophore and the rupture of the ether bond was 
expected to induce changes in the emission spectra of the fluorogenic subunit. This 
simple sensing mechanism was used, very recently, in the preparation of selective and 
sensitive chemodosimeters for HS
-
 anion in water and in cellular media (vide ante).(59-
61) The high selectivity obtained for HS
-
 versus thiols (vide infra) relies on the fact that 
H2S is a small molecule with a pKa of 6.9, while typical cellular free thiols (i.e. GSH 
and Cys) have pKa values of ca. 8.5.(65) Taking into account these differences, at 
physiological pH, the thiolysis of 2,4-dinitrophenyl ethers is chemoselective for HS
-
 











Figure 1. Emission intensity of D1 (at 515 nm upon excitation at 390 nm), D2 (at 415 nm upon 
excitation at 350 nm), D3 (at 516 nm upon excitation at 450 nm) and D4 (at 515 nm upon 
excitation at 450 nm) dosimeters (5 µM) in HEPES (10 mM, pH 7.4)-DMSO 99:1 v/v solutions 










































































































30 and 50 minutes of the addition for D1, D2, D3 and D4 respectively). The temperature was set 
at 25ºC. 
 
 In a first step we tested the fluorescent response of the probes D1-D4 (5 µM) in 
HEPES (10 mM, pH 7.4)-DMSO 99:1 v/v solution upon addition of an excess (10 































) and oxidants (H2O2). As it can be seen in Figure 1 the four 
dosimeters were practically non-fluorescent, however addition of HS
-
 induced a very 
remarkable fluorescent “turn-on” response, whereas addition of the other chemicals 
tested induced negligible changes in the emission behaviour. Besides, the fluorescent 
behavior of the four probes in the presence of GSH 6 mM (GSH concentrations in cells 
are in the 1-10 mM range) was also tested. As could be seen in Figure 2 GSH was 
unable to induce a remarkable fluorescent enhancement of the four probes even at mM 









Figure 2. Emission intensity of D1 (at 515 nm upon excitation at 390 nm), D2 (at 415 nm upon 
excitation at 350 nm), D3 (at 516 nm upon excitation at 450 nm) and D4 (at 515 nm upon 
excitation at 450 nm) dosimeters (5 µM) in HEPES (10 mM, pH 7.4)-DMSO 99:1 v/v solutions 
alone (white bars) and upon addition of 50 M GSH (light grey bars), 6 mM GSH (dark grey 
bars) and 50 mM HS
-











































Figure 3. Fluorescene enhancement of dosimeter D1 (5 µM) in HEPES (10 mM, pH 7.4)-
DMSO 99:1 v/v solution upon addition of increasing quantities of HS
-
 anion (from 0 to 10 









Figure 4. Fluorescene enhancement of dosimeter D2 (5 µM) in HEPES (10 mM, pH 
7.4)-DMSO 99:1 v/v solution upon addition of increasing quantities of HS
-
 anion (from 0 
to 10 equivalents) after 70 minutes of the addition (λex = 350 nm). The temperature was 
set at 25ºC. 
 
More in detail, addition of 10 equivalents of HS
-
 anion to HEPES (10 mM, pH 
7.4)-DMSO 99:1 v/v solution of dosimeter D1 induced the appearance of an emission 
band at 515 nm (λex = 390 nm) that reached its maximum intensity after 60 minutes (15-
fold enhancement) (see Figure 3). For D2, addition of HS
-
 induced a 46-fold 









































































Figure 5. Fluorescene enhancement of dosimeter D4 (5 µM) in HEPES (10 mM, pH 7.4)-
DMSO 99:1 v/v solution upon addition of increasing quantities of HS
-
 anion (from 0 to 10 









Figure 6. Fluorescene enhancement of dosimeter D3 (5 µM) in HEPES (10 mM, pH 7.4)-
DMSO 99:1 v/v solution upon addition of increasing quantities of HS
-
 anion (from 0 to 10 
equivalents) after 50 minutes of the addition (λex = 450 nm). The temperature was set at 25ºC. 
 
 Nearly the same enhancement (32-fold) in the intensity at 515 nm (λex = 450 nm) 
was obtained upon addition of HS
-
 anion to probe D4 (Figure 5). In this case the 
response was faster (when compared with D1 and D2) as the maximum enhancement 
was observed after 30 minutes upon HS
-
 addition. Besides, dosimeter D3 gives the 
larger response, in this case the addition of HS
-
 anion induced a remarkable 344-fold 
enhancement in the emission band at 516 nm (λex = 450 nm) after 50 minutes (see 
 
 

































































Figure 6). The subtle differences in response time and in emission enhancement upon 
addition of HS
-
 anion to the four dosimeters could be ascribed to the different electronic 
properties of the probes although in all cases a clear highly selective turn-on response 
was observed. 
 After assessing the highly selective turn-on response of D1-D4 to hydrogen 
sulfide, the sensitivity of the probes was studied from titration profiles with HS
- 
obtained in HEPES-DMSO 99:1 v/v solutions. From these studies a limit of detection 
(LOD) of 0.20 µM for HS
-
 was determined for D1. Nearly the same response and 
sensitivity was obtained with probe D2 (LOD = 0.29 µM). A more sensitive response 
was found on changing to dosimeters D3 and D4. In these cases the titration profiles 
obtained allowed to calculate LOD of 0.06 and 0.05 µM for D3 and D4, respectively. In 
all cases the probes displayed LODs below the hydrogen sulfide concentration required 
to elicit physiological responses (10-1000 µM).(66) 
 The selective emission enhancements observed for D1-D4 in the presence of HS
- 
is ascribed in all cases to an HS
-
-induced hydrolysis of the 2,4-dintrophenyl ether 
groups that results in the release of the highly fluorescent alcohols 1c, 2a, 3a and 4b. In 
order to corroborate this hypothesis probes D1-D4 were dissolved in ethanol and an 
excess of Na2S was added. The reactions were stirred at room temperature for 3 h and 
then the solvent was eliminated in a rotary evaporator. The crudes obtained were 




C confirmed the presence of the 
alcohols 1c, 2a, 3a and 4b (for D1, D2, D3 and D4 respectively) as main products of the 
reaction. 
 The sensing features of D1-D4 probes were quite similar to those reported for 
analogous fluorophores functionalized with 2,4-dinitrophenylethers (see Table 1). In 
particular, reaction times when using hydrolysis of 2,4-dinitrophenylether as sensing 
mechanism are in the range of minutes whereas the detection limits are in the 0.05-0.29 
µM interval. Table 1 also shows the typical sensing parameters for probes for hydrogen 
sulfide when using different sensing mechanisms. From the data in the table it is 
apparent that the best response, in terms of reaction time, are obtained with probes in 
which the sensing mechanism is related with demetallation of Cu(II) complexes (from 
few seconds to minutes).  As seen also in Table 1, lower limits of detection for 
hydrogen sulfide are obtained when demetallation processes and reduction reactions are 
used as transduction mechanisms. 
 
Table 1. Mechanism used in the development of fluorogenic probes for hydrogen sulfide. 
Mechanism Time Limit of detection References 
 hydrolysis of 2,4-dinitrophenylether (D1-D4) 30-70 minutes 0.05-0.29 µM this paper 
hydrolysis of 2,4-dinitrophenylether 5-20 minutes 0.05-0.48 µM 59-61 
demetallation of Cu(II) complexes few seconds-5 minutes 0.01-16 µM 37-46 
Michael addition reactions 2-60 minutes 0.12-1 µM 47-50 
other hydrolysis reactions 30-60 minutes 0.05-9 µM 54-56 
reduction reactions 3-120 minutes 0.01-5 µM 27-36 
oxidation of Se-containing fluorophores 5 minutes not reported 57,58 









Figure 7. Cell viability assays. Hela cells were treated with dosimeters D1 (black), D2 (dark 
grey), D3 (grey) and D4 (white) at concentrations of 5,10,20,50 μM during 24h. 
 
Cell viability assays: The selective emission enhancement of D1-D4 in the presence of 
HS
-
 and the poor response observed upon the addition of bio-thiols (GSH, Cys and Hcy) 
strongly suggest that these probes could be used for HS
- 
imaging in living cells. Based 
on these observations, the cytotoxicity of D1-D4 was first evaluated. For this purpose 
HeLa cells were treated with probes D1-D4 at different concentrations (5, 10, 20 and 50 
µM) over a 24-hour period and cell viability was determined by using a WST-1 assay. 
The obtained results are shown in Figure 7. As seen, the four dosimeters were 





 in HeLa cells: Once assessed the biocompatibility of the prepared 
probes, and with the aim to test the dosimeters in highly competitive environments, we 
prospectively used probes D1-D4 for the fluorescence imaging of sulfide in living cells. 
Of the four probes tested, only D1 and D3 gave remarkable results due to the low 













Figure 8. Detection of HS
-
 levels in living cells using dosimeter D1. (a, e)  Transmitted light 
and fluorescence images of untreated HeLa cells. (b, f) Hela cells incubated with D1 for 90 
minutes. (c, g) HeLa cells incubated with D1 for 30 minutes at 37 ºC and then with 200 µM 
Na2S for 60 minutes. (d, h) Hela cells incubated during 30 min with D1 and 500 µM Na2S for 
other 60 minutes. (i) Average If/I0 intensity ratios after addition of 200 and 500 µM of Na2S in 
PBS buffer. The excitation and emission wavelength were 450-470 nm and 510-530 nm. 
Representative fluorescence images from replicate experiments (n = 3) are shown. Error bars 
are (SD). 
 
 In a typical experiment, HeLa cells were incubated in DMEM supplemented 
with 10% fetal bovine serum. To conduct fluorescence microscopy studies, HeLa cells 
were seeded in 24 mm glass coverslips in 6-well plates and were allowed to settle for 24 
h. Cells were treated with the probes in PBS-DMSO 99:1 v/v at final concentrations of 
 
 I 
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10 and 30 μM, for D1 and D3 respectively. After 30 minutes, the medium was removed 
and solutions of different concentrations of NaHS in PBS were added (0, 100, 200 and 







Figure 9. Detection of HS
- 
levels in living cells using probe D3. HeLa cells were incubated with 
D3 (30 μM) for 30 min at 37
o
C in DMEM. Transmitted light and fluorescence images were 
captured for (a) Hela cells, (b) Hela cells incubated with D3, and Hela cells incubated with D3 
in the presence of HS
-
 at concentrations of (c) 200 μM and (d) 500 μM. The range of excitation 
was 330-380 nm and emission was monitored for wavelengths exceeding 420 nm. 
 
 The results are shown in Figures 8 (for D1) and 9 (for D3). The control 
experiment (HeLa cells without dosimeters) and the cells incubated with D1 and D3 
showed no fluorescence, whereas a clear and marked enhancement in intracellular 
emission was found in the HS
-
-treated cells. The emission enhancement observed was 
clearly dependent of the amount of NaHS added. The enhancement in the intracellular 
fluorescence intensity with D1 was quantified by a standard image analysis and the 
results are shown in Figure 8i. A similar response (not shown) was observed for D3. 
 
Conclusions 
In summary, here we reported the synthesis and sensing features of four compounds 
(D1-D4) as fluorescent turn-on probes for hydrogen sulfide. These chemodosimeters 
were based in a different fluorophores (i.e. styryl pyridine, naphthalene, quinoline and 
fluoresceine for D1, D2, D3 and D4, respectively) functionalized with a 2,4-
dinitrophenyl ether moiety. This chemical modification made the final probes poorly 
emissive. Probes D1-D4 were easy to prepare and were able to selectively detect the 
HS
-
 anion in HEPES(10 mM, pH 7.4)-DMSO 99:1 v/v solutions via a remarkable turn-
 
on emission. The emission enhancements observed were due to a selective sulfide-
induced hydrolysis of the 2,4-dinitrophenyl ether moiety that released the free 
fluorophores. D1-D4 can selectively and sensitively detected HS
-
 anion in water over 
other anions, biothiols and common oxidants. The titration profiles obtained upon 
addition of increasing quantities of HS
-
 anion to aqueous solutions of the four 
dosimeters allowed us to determine LODs of 0.20, 0.29, 0.06 and 0.05 µM for D1, D2, 
D3 and D4 respectively. Besides the four dosimeters showed remarkably low 
sensitivities below the hydrogen sulfide concentration required to elicit physiological 
responses. From cell viability assays it was found that the four probes were essentially 
non-toxic. Moreover, real-time fluorescence imaging measurements confirmed that 
probes D1 and D3 can be used to detect intracellular HS
-
 at micromolar concentrations. 
 
Experimental section 
Materials and methods: UV-visible spectra were recorded with a JASCO V-650 





C-NMR spectra were acquired in a BRUKER ADVANCE 
III (400 MHZ), where mass spectra were carried out in a TRIPLETOF T5600 
(ABSciex, USA) spectrometer.  The chemicals 4-picoline, 2-hydroxynaphthalene, 8-
hydroxyquinoline, fluorescein, iodomethane, 1-fluoro-2,4-dinitrobenzene, 4-
hydroxybenzaldehyde (98%), acetic anhydride (98%), hexadecyltrimethylammonium 
bromide (CTABr) and sodium bicarbonate were purchased from Sigma-Aldrich. 
Triethylamine (98%) was purchased from J. T. Baker. Analytical-grade solvents, 
potassium hydroxide, sodium sulfate and hydrochloric acid (37%) were purchased from 
Scharlau (Barcelona, Spain). 
Synthesis of 4-((E)-2-(pyridin-4-yl)vinyl)phenol (1c): 4-hydroxybenzaldehyde (1a, 
500 mg, 4.1 mmol) and 4-picoline (1b, 0.4 mL, 4.1 mmol) were refluxed in acetic 
anhydride (5 mL) for 24 h. After cooling to room temperature a precipitate appeared. 
This was collected and recrystallized from ethanol. Then, the solid was dissolved in 
ethanol-water (20 mL, 1:1 v/v) containing potassium hydroxide (400 mg, 7.1 mmol) and 
refluxed for 6 h. Afterwards, the crude reaction was neutralized with diluted 
hydrochloric acid. The product 1c precipitated and was isolated as a yellow solid after 
filtration (749 mg, 3.8 mmol, 85% yield). 
1
H NMR (400 MHz, DMSO) δ 12.10 (s, 1H), 10.79 (d, J = 5.6 Hz, 2H), 9.75 (dd, J = 
21.4, 11.6 Hz, 5H), 9.29 (d, J = 16.4 Hz, 1H), 9.10 (d, J = 8.5 Hz, 2H). 
Synthesis of 4-(4-(2,4-dinitrophenoxy)styryl)pyridine  (D1):  1c (200 mg, 1.17 
mmol) was dissolved in acetone (5 mL) and then triethyl amine (0.5 ml, 3.6 mmol) was 
added. After that, 1-fluoro-2,4-dinitrobenzene (217.7 mg, 1.17 mmol) dissolved in 
acetone (5 mL) was added to the crude reaction and the mixture refluxed for 30 min.  
Then, he acetone was evaporates and the residue taken up in 5% hydrochloric acid (10 
mL). A precipitate appeared that was filtered, washed with water and then suspended in 
5% sodium hydroxide (15 mL) and stirred for 15 min. After that, the solid was filtered, 
washed with water and purified by silica column chromatography using hexane-acetone 
1:1 v/v as eluent.  Dosimeter D1 was isolated as yellow solid (310 mg, 0.85 mmol, 74% 
yield). 
1
H NMR (400 MHz, DMSO) δ 8.91 (d, J = 2.8 Hz, 1H), 8.56 (d, J = 6.0 Hz, 2H), 8.47 
(dd, J = 9.3, 2.8 Hz, 1H), 7.81 (d, J = 8.7 Hz, 2H), 7.57 (dd, J = 4.9, 3.4 Hz, 3H), 7.34 – 
7.25 (m, 4H). 
13
C NMR (101 MHz, CDCl3) δ 154.7, 153.9, 150.1, 144.2, 141.6, 139.6, 134.3, 131.8, 
129.7, 129.4, 126.6, 122.0, 121.0, 120.7, 119.7. 
HRMS-EI m/z: calcd for C19H13N3O5 363.0855; found: 364.0944 (M+H
+
). 
Synthesis of 2-(2,4-dinitrophenoxy)naphthalene (D2): Dosimeter D2 was prepared by 
the same experimental procedure used for D1. The final product was isolated as pale 
yellow solid (725 mg, 2.33 mmol, 88 % yield). 
1
H NMR (400 MHz, CDCl3) δ 8.97 (d, J = 2.7 Hz, 1H), 8.41 (dd, J = 9.3, 2.7 Hz, 1H), 
8.09 (d, J = 8.9 Hz, 1H), 8.04 – 8.00 (m, 1H), 7.96 – 7.92 (m, 1H), 7.67 (ddd, J = 9.4, 
4.2, 2.3 Hz, 3H), 7.40 – 7.37 (m, 1H), 7.18 (s, 1H). 
13
C NMR (101 MHz, CDCl3) δ 156.3, 151.2, 141.6, 139.6, 134.2, 131.7, 131.2, 128.9, 
128.1, 127.6, 126.5, 122.2, 119.7, 118.8, 117.6. 
HRMS-EI m/z: calcd for C16H10N2O5 310.0590; found: 310.0817 (M
+
). 
Synthesis of 8-(2,4-dinitrohydroxy)quinoline (D3): Dosimeter D3 was prepared by 
the same experimental procedure used for D1. The final product was isolated as pale 
yellow solid (703 mg, 2.25 mmol, 85 % yield). 
1
H NMR (400 MHz, CDCl3) δ 8.93 (d, J = 2.8 Hz, 1H), 8.79 (dd, J = 4.2, 1.7 Hz, 1H), 
8.25 (dd, J = 8.4, 1.7 Hz, 1H), 8.18 (dd, J = 9.3, 2.8 Hz, 1H), 7.83 (dd, J = 7.9, 1.7 Hz, 
1H), 7.65 – 7.56 (m, 2H), 7.47 (dd, J = 8.4, 4.2 Hz, 1H), 6.79 (d, J = 9.3 Hz, 1H). 
13
C NMR (101 MHz, CDCl3) δ 157.4, 151.0, 149.4, 141.4, 140.6, 138.9, 136.4, 130.3, 
128.7, 126.8, 122.4, 120.9. 
HRMS-EI m/z: calcd for C15H10N3O5 311.0542; found: 312.0628 (M+H
+
). 
Synthesis of 3-hydroxy-6-methoxy-3H-spiro[isobenzofuran-1,9-xanthen]-3-one 
(4b): Fluorescein (4a, 2 g, 6.18 mmol) was suspended in methanol (50 mL) and NaOH 
(160 mg, 4 mmol) was then added. The final mixture was stirred until complete 
dissolution of fluorescein. After evaporation of methanol, the disodium salt (2.0 g, 5.32 
mmol) was suspended in DMF (50 mL) containing methyl iodide (332 µL, 5.32 mmol) 
and the reaction was then stirred at room temperature for 48 h. After this time, the crude 
was diluted with 5% NaHCO3 (50 mL) and extracted with diethyl ether (2 x 25 mL). 
The organic phase was washed with brine (20 mL), dried over Na2SO4, and evaporated 
to give an orange precipitate. This solid was dissolved in methanol (30 mL), 2M NaOH 
(10 mL) was added and the mixture stirred at room temperature for 2 h. After 
evaporation of methanol, the crude was diluted with water (20 mL) and impurities 
extracted with diethyl ether (2 x 10 mL). The aqueous phase was acidified (pH 2.0) by 
the addition of concentrated HCl and then extracted with diethyl ether (3 x 15 mL), 
washed with brine (25 mL) and dried over Na2SO4. After evaporation of the diethyl 
ether a brown solid was obtained. The final product was purified by silica column 
chromatography using diethyl ether-hexane 2:1 v/v as eluent. Compound 4b was 
isolated as brown solid (831.2 mg, 2.4 mmol, 45% yield). 
Synthesis of 3-(2,4-dinitrophenoxy)-6-methoxy-3H-spiro[isobenzofuran-1,9-
xanthen]-3-one  (D4): Dosimeter D4 was prepared by the same experimental procedure 
used for D1. The final product was isolated as brown solid (162 mg, 0.315 mmol, 65 % 
yield). 
1
H NMR (400 MHz, DMSO) δ 8.84 (d, J = 2.8 Hz, 1H), 8.58 (d, J = 3.1 Hz, 1H), 8.45 
(dd, J = 9.2, 2.6 Hz, 1H), 8.01 (d, J = 7.6 Hz, 1H), 7.90 – 7.77 (m, 1H), 7.73 (t, J = 7.3 
Hz, 1H), 7.37 (d, J = 9.2 Hz, 1H), 7.22 (dd, J = 9.8, 5.1 Hz, 1H), 6.92 (ddd, J = 20.1, 
13.2, 5.6 Hz, 1H), 6.74 (dd, J = 8.9, 2.5 Hz, 1H), 6.67 (d, J = 8.8 Hz, 1H), 6.45 (d, J = 
9.7 Hz, 1H), 3.76 (s, 1H). 
13
C NMR (101 MHz, DMSO) δ 158.3, 155.0, 144.7, 141.2, 140.9, 139.1, 138.7, 138.5, 
136.6, 129.7, 127.9, 126.6, 126.0, 125.8, 125.6, 124.8, 123.0, 121.7, 120.3, 117.8, 
114.8, 115.8, 113.0, 110.1, 107.8, 56.1, 18.6. 
HRMS-EI m/z: calcd for C27H16N2O9 512.0856; found: 513.0935 (M+H
+
). 
Cell culture conditions: The HeLa human cervix adenocarcinoma cells were purchased 
from the German Resource Centre for Biological Materials (DSMZ) and were grown in 
DEM supplemented with 10% FBS. Cells were maintained at 37 ºC in an atmosphere of 
5% CO2 and 95% air ad underwent passage twice in a week. 
WST-1 cell viability assays: Cells were cultured in sterile 96 –well plates at a seeding 
density of 2.5 x 10
3
 cells/well for HeLa and were allowed to settle for 24 h. Dosimeters 
D1, D2, D3 and D4 were added to the cells at final concentrations of 10, 20, 30 and 50 
µM. After 23 h, WST-1 (7 µL of a 50 mg/ml solution) was added to each well. Cells 
were further incubated for 1 h (a total of 24 h of incubation was therefore studied). Then 
shacked thoroughly for 1 min. on a shaker and the absorbance was measured at 450 nm 
against a background control as blank using a microplate ELISA reader. The reference 
wavelength is 690 nm. 
Live confocal microscopy: Hela cells were seeded in 24 mm glass coverslips in 6-well 
plates at a seeding density of 10
-5 
cells/well. After 24 hours, cells were treated with D1 
and D3 at a final concentration of 10 and 30 μM, respectively. After 30 minutes, the 
medium was removed to eliminate compounds and washed with PBS. Then a solution 
of Na2S in PBS was added at a final concentrations of 0, 100, 200, 500 μM and cells 
were incubated during 1h at 37 ºC. After that, slides were washed twice with PBS to 
remove traces of the dosimeters. Then slides were visualized under a confocal. Confocal 
microscopy studies were performed by Confocal Microscopy Service (CIPF). The 
images were acquired with a Leica TCS SP2 AOBS (Leica Microsystems Heidelberg 
GmbH, Mannheim, Germany) inverted laser scanning confocal microscope using oil 
objectives: 63X Plan-Apochromat-Lambda Blue 1.4 N.A. The excitation wavelengths 
were 450 nm (argon laser) for both dosimeters. Two-dimensional pseudo colour images 
(255 colour levels) were gathered with a size of 1024 x 1024 pixels and Airy 1 pinhole 
diameter. All confocal images were acquired using the same settings and the 
distribution of fluorescence was analyzed using the Image J Software. Identical 
experiments were done three times to obtain reproducible results. 
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